Scribd
Upload
21 views

TG21530886 Report 1

Uploaded by

jaimonjoy85
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
21 views

TG21530886 Report 1

Uploaded by

jaimonjoy85
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

DDRC SRL DIAGNOSTICS PRIVATE LIMITED

Building No. KP.V/210(1),Ground Floor,


Civil Station Entrance Road,Kudappanakunnu,TVM-695 043
Tel : 9446508100, mail: [email protected]
CIN:U85190MH2006PTC161480
Name :MR.JOY VARUGHESE Age/Sex : 70/M SRD No : TU218438-O/KUD
Doctor : SELF (COUNTER CASH) Sample Collected 29/07/2021 02:04 PM Ref. No : R 9040044
Report On : 29/07/2021 07:55 PM IP/OP No: R 9040044
Hospital: COUNTER CASH
SRF No: 1006/TVM/20210746864 Phone No: 9847388892
Test Description Value Observed Reference Range

DEPARTMENT OF GENETICS
COVID-19 RT PCR
Specimen Nasopharyngeal / oropharyngeal Swab

E Gene NOT DETECTED

RdRP/N / ORF1ab Gene NOT DETECTED


Result SARS CoV-2 RNA NOT DETECTED
Final Report NEGATIVE

Notes:

ICMR Reg No : DDRCSRLDPTK


Test Performed at : DDRC SRL Diagnostics Pvt Ltd , Building No.82/1730(2), Mridunga Tower, Pattoor Road, Trivandrum, ICMR approved centre

Method: Real-time PCR


This is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from the 2019-nCoV in upper and lower respiratory specimens (such as
nasopharyngeal or oropharyngeal swabs, sputum, lower respiratory tract aspirates, bronchoalveolar lavage, and nasopharyngeal wash/aspirate or nasal aspirate)
collected from individuals who meet 2019-nCoV clinical and/or epidemiological criteria. The assay uses RNA extracted from clinical samples. Using the RNA
extracted, the assay performs the RT-PCR reaction by dividing it into two assays for accurate detection of SARS-CoV-2. Each assay amplifies E gene and the
COVID -19 specific target, RdRp/N/ORF1ab gene, if present; thus it is designed for both the screening and specific detection of 2019-nCoV.

Pathogen information:
Coronaviruses are non-segmented positive-stranded RNA viruses with a roughly 30 kb genome surrounded by a protein envelope. Most coronaviruses cause
diseases in their particular host species; those that can infect humans through cross-species transmission have become an important threat to public health.
Since December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hasbeen recognised as the causal factor in a series of severe cases of
pneumonia originating in Wuhan in Hubei province, China. This disease has been named coronavirus disease 2019 (COVID-19) by WHO. Severe acute
respiratory syndrome-related coronavirus (SARSr-CoV) is a species of coronavirus that infects humans, bats and certain other mammals. It is a member of the
genus Betacoronavirus and subgenus sarbecoronavirus. Two strains of the virus have caused outbreaks of severe respiratory diseases in humans: SARS-CoV ,
which caused the 2002-2004 outbreak of severe acute respiratory syndrome (SARS), and SARS-CoV-2, which is causing the 2019–20 pandemic of coronavirus
disease 2019 (COVID-19). Other strains of Sarbecovirus are only known to infect non-human species: bats are a major reservoir of many strains.

Interpretation:
Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to
determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses.

Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be
combined with clinical observations, patient history, and epidemiological information. A false negative result may occur, if inadequate number of organisms are
present in the specimen due to improper collection, transport or handling. False negative results may also occur if amplification inhibitors are present in the
specimen. A single negative test result, particularly if this is from an upper respiratory tract specimen, does not exclude infection. Repeat sampling and testing
of lower respiratory specimen is strongly recommended in severe or progressive disease. The repeat specimens may be considered after a gap of 2 – 4 days after
the collection of the first specimen for additional testing if required.

Status : FINAL REPORT

Dr. SAMITHA NAIR Dr.RATHEESHKUMAR T


MBBS, MD, DipRCPath, Pg Dip(ID) Ph.D, (Molecular Biology)
Dept.of Micro & Molecular Biology HOD Molecular Biology and Genetics

** End Of Report ** Bd No:82/1730(2) DDRC SRL,TVM,Ph: 8590600766 Bd No:82/1730(2) Ph:8590600766


This Report has been digitally signed by system, hence manual signatory is not necessary Reviewed By Approved By

Page 1 of 1

You might also like